Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD44 antibodies inhibit osteoclast formation

J R Kania1, T Kehat-Stadler, S R Kupfer

  • 1Department of Pediatrics, Washington University, St. Louis, Missouri, USA.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|August 1, 1997
PubMed
Summary

CD44, a cell surface glycoprotein, is crucial for osteoclast differentiation. Blocking CD44 with antibodies inhibits bone cell formation, highlighting its role in this complex process.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Specificity of simple hormone response elements in androgen regulated genes.

Endocrine·2010
Same author

Periodontal disease and habits; the effects and treatment of several habits detrimental to the periodontium.

Dental student·2010
Same author

Genomic sequence of the DAX1 gene: an orphan nuclear receptor responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism.

The Journal of clinical endocrinology and metabolism·1996
Same author

Prevention of dry socket with clindamycin. A retrospective study.

The New York state dental journal·1995
Same author

Androgen and glucocorticoid receptors interact with insulin degrading enzyme.

The Journal of biological chemistry·1994
Same author

Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors.

The Journal of biological chemistry·1993

Area of Science:

  • Cell Biology
  • Immunology
  • Bone Biology

Background:

  • Osteoclast differentiation is a complex, multi-step process.
  • CD44, a cell surface glycoprotein, acts as an adhesion receptor.
  • The precise role of CD44 in osteoclastogenesis remains to be fully elucidated.

Purpose of the Study:

  • To investigate the involvement of CD44 in osteoclast differentiation.
  • To determine the mechanism by which CD44 influences osteoclast formation.

Main Methods:

  • Immunocytochemistry to detect CD44 expression in differentiating osteoclasts.
  • Inhibition assays using monoclonal antibodies and Fab fragments against CD44.
  • Coculture systems involving hematopoietic and stromal cells.

Related Experiment Videos

Main Results:

  • CD44 is expressed on mouse osteoclasts during differentiation induced by 1 alpha, 25-dihydroxyvitamin D3.
  • Monoclonal antibodies against CD44 significantly inhibit osteoclast formation in a dose- and time-dependent manner.
  • Inhibition is mediated by cross-linking of CD44 molecules, as Fab fragments lack this effect, and hematopoietic cells are involved.

Conclusions:

  • CD44 plays a significant role in the formation of osteoclasts.
  • Antibody-mediated cross-linking of CD44 is essential for inhibiting osteoclast differentiation.
  • CD44 is not essential for the resorption activity of mature osteoclasts.